Abstract:Background/Purpose: Although the precise pathogenesis for the destruction of the intrahepatic biliary tract in a patient with biliary atresia (BA) is still unclear, it is known that progressive destruction of the intrahepatic biliary tract is responsible for poor long-term outcome after surgical treatment. In this study, the authors evaluated the expression of HLA-DR in liver tissue of patients with BA to explore its role in the pathogenesis of this disease.Methods: Liver biopsy specimens from patients with BA (n = 14) and normal liver biopsies (n = 12) were studied immunohistochemically and were assessed immune electron microscopically to detect the expression of HLA-DR. All patients underwent follow-up for at least 3 months after surgery evaluating the short-term postoperative outcome by monitoring the serum bilirubin level during jaundice persistency.Results: The immunohistochemical examinations showed in 10 of 14 liver specimens in the BA group a positive expression of HLA-DR. This expression was mainly detected in bile ducts of the central portal area rather than in proliferated ones in more peripheral areas. None of the specimens from the control group showed positive expression. Eight of 14 specimens in the BA group showed immunoelectron microscopic depositions of colloidal gold in dull and swollen ductules microvilli. This was not observed in the control group. In patients with BA there was an inverse relationship between short-term postoperative outcome and expression of HLA-DR in intrahepatic ductules.Conclusions: Our findings show that there is an aberrant expression of HLA-DR in microvilli of the ductules in patients with BA, and this abnormal expression is inversely related to the short-term postoperative outcome. It is suggested that aberrant HLA-DR expression in bile ductules may play a pathogenic role in progressive damage to the intrahepatic bile ducts in BA. (C) 2004 Elsevier Inc. All rights reserved.

A novel model of injured liver ductal organoids to investigate cholangiocyte apoptosis with relevance to biliary atresia

The Aberrant Expression of HLA-DR in Intrahepatic Bile Ducts in Patients with Biliary Atresia: an Immunohistochemistry and Immune Electron Microscopy Study.

Animal and organoid models to elucidate the anti-fibrotic effect of steroid on biliary atresia

Organoids and Spheroids as Models for Studying Cholestatic Liver Injury and Cholangiocarcinoma

Liver Organoids, Novel and Promising Modalities for Exploring and Repairing Liver Injury

Integrative single-cell and spatial transcriptomic analyses identify a pathogenic cholangiocyte niche and TNFRSF12A as therapeutic target for biliary atresia

Modeling bile duct ischemia and reoxygenation injury in human cholangiocyte organoids for screening of novel cholangio-protective agents

Human Hepatobiliary Organoids: Recent Advances in Drug Toxicity Verification and Drug Screening

Generation of Fibrotic Liver Organoids Using Hepatocytes, Primary Liver Sinusoidal Endothelial Cells, Hepatic Stellate Cells, and Macrophages

Biliary atresia: insights into mechanisms using a toxic model of the disease including Wnt and Hippo signaling pathways and microtubules

Three-Dimensional Organoids as a Model to Study Nonalcoholic Fatty Liver Disease

Customized liver organoids as an advanced in vitro modeling and drug discovery platform for non-alcoholic fatty liver diseases

Environmental Toxin Biliatresone-Induced Biliary Atresia-like Abnormal Cilia and Bile Duct Cell Development of Human Liver Organoids

Cholangiocyte organoids to study drug-induced injury

Human branching cholangiocyte organoids recapitulate functional bile duct formation

Insight to Biofabrication of Liver Microtissues for Disease Modeling: Challenges and Opportunities

Bioengineered Tubular Biliary Organoids

A novel model to study mechanisms of cholestasis in human cholangiocytes reveals a role for the SIPR2 pathway

Cholangiocyte organoids can repair bile ducts after transplantation in the human liver

Exploiting the plasticity of cholangiocytes to repair the biliary tree

A novel model based on immune-related genes for differentiating biliary atresia from other cholestatic diseases